GoodRx Adds Telehealth and Mail Order to GoodRx Gold Savings Program

GoodRx Gold members can now receive significant discounts on doctor visits, prescriptions and mail delivery

SANTA MONICA, Calif.--(BUSINESS WIRE)--Dec. 16, 2020-- GoodRx (Nasdaq: GDRX), America’s leading source for healthcare savings, today announced expanded benefits for its subscription program, GoodRx Gold. Members can now receive exclusive discounts on online doctor visits and free mail delivery via the GoodRx app, in addition to the exclusive lower prices on prescription drugs that are already available. With these new offerings, GoodRx Gold now makes every step of a patient’s healthcare journey easier and more affordable, from seeing a doctor to filling the medication you are prescribed, all without leaving your home.

During the COVID-19 pandemic, concerns around accessing in-person care have driven many consumers to try telehealth. While only ~10% of consumers had used telehealth as of 2019, more than 75% of consumers now report being interested in using telehealth, according to a recent McKinsey consumer survey. Use of telehealth soared nearly 30 fold from September 2019 to September 2020, particularly for chronic conditions and for mental health, according to FAIR Health.

“Our mission at GoodRx has always been to get Americans the healthcare they need at a price they can afford,” said GoodRx co-CEO and co-founder Doug Hirsch. “Over the past year, we have launched several new services - HeyDoctor by GoodRx and telehealth & labs marketplaces - which make accessing care easier and more affordable for consumers. With these improvements to GoodRx Gold, we are expanding access to even more people and delivering deeper savings than are available anywhere else on the market.”

Using the 5-star rated GoodRx app, GoodRx Gold members can now see a licensed healthcare provider to receive treatment in the comfort and safety of their own home. Visits for members start at just $10 (55% off non-member rates) and patients can be seen for over 150 conditions, including cold and flu, UTI, cold sores, acne, birth control, COVID-19 screenings, refills for common medications and more. If the patient is prescribed medication, they can use a GoodRx Gold discount of up to 90% at pharmacies near them or have it sent directly to their house via free mail delivery.

GoodRx Gold now offers more than 1,000 common, low-priced medications via mail delivery, with nearly 300 of them priced under $10. To get started, simply open the GoodRx app and enter your prescription information. Members can also transfer their prescriptions in-app from a brick-and-mortar pharmacy to mail order. Eligible drugs have a Gold mail delivery sticker on the drug’s price page. GoodRx’s mail delivery pharmacy partner, Truepill, is fully accredited by URAC and NABP and ships medications to all 50 states and the District of Columbia.

After a 30-day free trial, GoodRx Gold is just $5.99 per month for individuals or $9.99 per month for a family with up to six members, including pets. The average GoodRx Gold member saves more than $2,875 each year, while the GoodRx Gold family plan saves families an average of $3,323 each year. Customers can sign up for GoodRx Gold at or in the GoodRx mobile app. GoodRx Gold is available in 49 states, excluding Washington state.

To learn more about GoodRx Gold, visit:

About GoodRx

GoodRx helps Americans get the healthcare they need at a price they can afford. As America’s leading resource for healthcare savings, GoodRx connects consumers with affordable and convenient prescriptions and medical care, including telehealth, mail-order prescriptions, doctor visits, and lab tests. We have helped Americans save over $25 billion since 2011 and are the #1 most downloaded medical app in the last three years.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the demand for telehealth services, our product offerings, potential cost savings to consumers and our business strategy. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks related to our limited operating history and early stage of growth; our ability to achieve broad market education and change consumer purchasing habits; our ability to continue to attract, acquire and retain consumers in a cost-effective manner; our reliance on our prescription offering and ability to expand our offerings; changes in medication pricing and pricing structures; our inability to control the categories and types of prescriptions for which we can offer savings or discounted prices; risks related to the COVID-19 pandemic; our ability to respond to changes in the market for prescription pricing and to maintain and expand the use of GoodRx codes; and the other important factors discussed in our Quarterly Report on Form 10-Q for the three months ended September 30, 2020 and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

Lauren Casparis

Source: GoodRx

site - Investor Tools